Companion Animal Diagnostics Market to Reach USD 6.88 Billion, Globally, by 2031 at 8.6% CAGR: Allied Market Research

Rise in the prevalence of zoonotic diseases in animals, surge in technological advancements in point-of-care diagnostics, and increase in disposable income levels in the developing regions drive the growth of the global companion animal diagnostics market.

PORTLAND, Ore., Aug. 17, 2022 /PRNewswire/ -- Allied Market Research published a report, titled, 'Companion Animal Diagnostics Market By Technology (Clinical Biochemistry, Immunodiagnostics, Molecular Diagnostics, Hematology, Urinalysis, Others), By Application (Clinical Pathology, Bacteriology, Virology, Parasitology, Other Applications), By Animal Type (Dogs, Cats, Others), By End User (Diagnostic Labs, Veterinary Hospitals and Clinics, Point-Of-Care and In-House Testing, Research Institutes and Universities): Global Opportunity Analysis and Industry Forecast, 2021-2031.' According to the report, the global companion animal diagnostics industry was estimated at $2.99 billion in 2021, and is anticipated to hit $6.88 billion by 2031, registering a CAGR of 8.6% from 2022 to 2031. The report offers an explicit analysis of the changing market trends, top segments, key investment pockets, value chain, competitive scenario, and regional landscape. The market study is exclusively meant to help the readers with a complete valuation of industry analysis and trends.

Download Sample Report - https://www.alliedmarketresearch.com/request-sample/11492

Drivers, restraints, and opportunities-

Rise in the prevalence of zoonotic diseases in animals, surge in technological advancements in point-of-care diagnostics, and increase in disposable income levels in the developing regions drive the growth of the global companion animal diagnostics market. On the other hand, lack of skilled veterinary professionals impedes the growth to some extent. However, surge in awareness associated with animal healthcare and increase in adoption of rapid tests and portable instruments in point-of-care diagnostics are projected to create lucrative opportunities in the industry.

Covid-19 Scenario-

• Increase in the number of Covid-19 infections in animals had alarmed various veterinary organizations across the world to evaluate specimens for diagnosis from domesticated as well as companion animals for the virus. This factor had a positive impact on the global companion animal diagnostics market. For example, according to the NCBI in 2020, around 40% of animals were diagnosed with the Covid-19 virus out of which 39% of dogs were affected in the United States.
• Moreover, companion animals diagnosed with Covid-19 have been used for experimental testing of SARS-CoV-2 veterinary vaccines, which serves as a valuable model for screening vaccines and antiviral drugs. This factor has again boosted the market growth.

Get detailed COVID-19 impact analysis on the Companion Animal Diagnostics Market- https://www.alliedmarketresearch.com/request-for-customization/11492?reqfor=covid

The clinical biochemistry segment to dominate by 2031-

Based on technology, the clinical biochemistry segment held around one-third of the global companion animal diagnostics market revenue in 2021, and is expected to lead the trail by 2031. The same segment would also manifest the fastest CAGR of 9.4% from 2022 to 2031. This is attributed to the spike in the number of pet adoptions and surge in awareness related to pet healthcare among pet owners.

The clinical pathology segment to rule the roost-

Based on application, the clinical pathology segment generated the major share in 2021, holding more than one-third of the global companion animal diagnostics market, and is projected to dominate throughout the forecast period. The same segment would also cite the fastest CAGR of 9.2% by 2031, due to rise in the incidence of chronic diseases such as rabies virus, skin diseases, and others.

The dogs segment to maintain the lion's share-

By animal type, the dogs segment contributed to nearly half of the global companion animal diagnostics market share in 2021, and is expected to retain its dominance by 2031. The same segment is also expected to exhibit the fastest CAGR of 8.9% from 2022 to 2031. Increase in the number of companion animals such as dogs across the world and rise in the incidence of zoonotic diseases in dogs are the major factors fueling the segment growth.

For Purchase Inquiry- https://www.alliedmarketresearch.com/purchase-enquiry/11492

North America garnered the major share in 2021-

Based on region, North America held the major share in 2021, generating nearly half of the global companion animal diagnostics market, owing to increase in the prevalence of chronic diseases among these animals. Asia-Pacific, simultaneously, would garner the fastest CAGR of 10.2% by 2031. This is due to surge in the population of companion animals, growing demand for diagnostics services from the livestock industry, and increasing expenditure to restore the health of the animals.

Key players in the industry-

• Thermo Fisher Scientific, Inc
• Zoetis, Inc
• Agrolabo spa
• Biomerieux SA
• Virbac
• Indical Bioscience Gmbh
• Fujifilm Holdings Corporation
• Triviumvet
• Neogen Corporation
• Shenzhen Mindray Animal Medical Technology Co. Ltd
• BioNote Inc
• Creative Diagnostics
• Heska Corporation
• HyTest Ltd
• Idexx Laboratories Inc
• IDvet
• Randox Laboratories Ltd

The report analyzes these key players in the global companion animal diagnostics market. These players have incorporated various strategies such as expansion, new product launches, partnerships, and others to increase their market penetration and strengthen their position in the industry. The report is helpful in assessing the operating segments, their business performance & product portfolio, and so on.

Official Press Release- Official Press Release- https://www.alliedmarketresearch.com/press-release/companion-animal-diagnostics-market.html

Similar Research Reports for Information, Communication and Technology:

Syphilis Testing Market- Global Opportunity Analysis and Industry Forecast, 2021?2030

mHealth Market- Global Opportunity Analysis and Industry Forecast, 2021?2030

3D Cell Culture Market- Global Opportunity Analysis and Industry Forecast, 2021?2030

Neurovascular Devices Market- Global Opportunity Analysis and Industry Forecast, 2021?2030

Neuroprosthetics Market- Global Opportunity Analysis and Industry Forecast, 2021?2030

AVENUE- A Subscription-Based Library (Premium on-demand, subscription-based pricing model):

AMR introduces its online premium subscription-based library Avenue, designed specifically to offer cost-effective, one-stop solution for enterprises, investors, and universities. With Avenue, subscribers can avail an entire repository of reports on more than 2,000 niche industries and more than 12,000 company profiles. Moreover, users can get an online access to quantitative and qualitative data in PDF and Excel formats along with analyst support, customization, and updated versions of reports.

Get an access to the library of reports at any time from any device and anywhere. For more details, follow the link: https://www.alliedmarketresearch.com/library-access

About Allied Market Research:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: 1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
[email protected] 
Web: https://www.alliedmarketresearch.com

Logo: https://mma.prnewswire.com/media/636519/Allied_Market_Research_Logo.jpg